4.8 Article

Potent inhibition of microRNA in vivo without degradation

期刊

NUCLEIC ACIDS RESEARCH
卷 37, 期 1, 页码 70-77

出版社

OXFORD UNIV PRESS
DOI: 10.1093/nar/gkn904

关键词

-

资金

  1. National Institutes of Health [R43 AI072802]
  2. Regulus Therapeutics
  3. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI072802] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Chemically modified antisense oligonucleotides (ASOs) are widely used as a tool to functionalize microRNAs (miRNAs). Reduction of miRNA level after ASO inhibition is commonly reported to show efficacy. Whether this is the most relevant endpoint for measuring miRNA inhibition has not been adequately addressed in the field although it has important implications for evaluating miRNA targeting studies. Using a novel approach to quantitate miRNA levels in the presence of excess ASO, we have discovered that the outcome of miRNA inhibition can vary depending on the chemical modification of the ASO. Although some miRNA inhibitors cause a decrease in mature miRNA levels, we have identified a novel 2-fluoro/2-methoxyethyl modified ASO motif with dramatically improved in vivo potency which does not. These studies show there are multiple mechanisms of miRNA inhibition by ASOs and that evaluation of secondary endpoints is crucial for interpreting miRNA inhibition studies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据